Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
ADPT Adaptive Biotechnologies
- 6.300
- +0.140+2.27%
Close Dec 13 16:00 ET
- 6.300
- 0.0000.00%
Post 18:42 ET
929.75MMarket Cap-4.70P/E (TTM)
6.365High5.980Low1.18MVolume6.110Open6.160Pre Close7.35MTurnover1.35%Turnover RatioLossP/E (Static)147.58MShares7.06752wk High4.16P/B554.25MFloat Cap2.28052wk Low--Dividend TTM87.98MShs Float71.250Historical High--Div YieldTTM6.25%Amplitude2.280Historical Low6.208Avg Price1Lot Size
About Adaptive Biotechnologies Company
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Company Profile
SymbolADPT
Company NameAdaptive Biotechnologies
Listing DateJun 27, 2019
Issue Price20.00
Founded2009
CEOMr. Chad M. Robins
MarketNASDAQ
Employees709
Fiscal Year Ends12-31
Address1165 Eastlake Avenue East
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98109
Phone1-206-659-0067
Company Executives
- Name
- Position
- Salary
- Chad M. Robins
- Chairman of the Board and Chief Executive Officer
- 8.90M
- Dr. Sharon Benzeno, PhD
- Chief Commercial Officer, Immune Medicine
- 2.88M
- Dr. Harlan Robins, PhD
- Chief Scientific Officer
- 8.61M
- Susan Bobulsky
- Chief Commercial Officer, Minimal Residual Disease
- --
- Julie Rubinstein
- President and Chief Operating Officer
- 2.97M
- Kyle Piskel
- Chief Financial Officer and Principal Accounting Officer
- --
- Francis Lo
- Chief People Officer
- --
- Stacy L. Taylor
- Senior Vice President, General Counsel and Corporate Secretary
- --
- Dr. Robert M. Hershberg, M.D.,PhD
- Independent Director
- 325.00K
- Dr. Michael J. Pellini,M.D.
- Independent Director
- 310.00K
- Peter M. Neupert
- Lead Independent Director
- 355.00K
- Michelle Griffin
- Independent Director
- 330.00K
- Katey Einterz Owen
- Independent Director
- 310.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.